Short description
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Description
Going Beyond Antibiotics®
Developing Anti-Infective Compounds Effective Against Bacteria, Viruses and Fungi.
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market. We are currently focused primarily on commercializing prescription Avenova® for managing hygiene of the eyelids and lashes in the United States.
Avenova is the only eye care product formulated with a proprietary, stable and pure form of hypochlorous acid called Neutrox®. By replicating the anti-microbial chemicals used by white blood cells to fight infection, Neutrox has proven in laboratory testing to have broad antimicrobial properties. Avenova with Neutrox removes debris from the skin on eyelids and lashes without burning or stinging.
We have developed additional commercial products containing Neutrox, including our NeutroPhase® Skin and Wound Cleanser for wound care and CelleRx® for the dermatology market. We have partnerships for NeutroPhase in the U.S. as well as select overseas markets, most notably China.
In addition to our Neutrox family of products, we have also synthesized and developed a second category of novel compounds aimed at harnessing the power of white blood cell chemistry to address the global, topical anti-infective market. This second product category includes auriclosene, our lead clinical-stage Aganocide® compound, which is a patented, synthetic molecule with a broad spectrum of activity against bacteria, viruses and fungi.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Emeryville, California, United States, North America
Founded on
January 1, 2000
Exited on
October 26, 2007
Went public on
October 26, 2007
Stock symbol
NBY
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccessforu, Uh Ohhhh, Noaccessforu, Absolutely Noaccess, Cannot Access
Sign in for full access
Founders
Ron Najafi